CP and infection: All three recombinants were also able to overcome the resistance of PRSV-PLDMV CP transgenic lines23 (Fig. 1C), with infection rates as high as 95-100% in the four tested lines 9-5, 10-4, 12-4, and 14-123 at eight weeks after inoculation (Table 2).